Southern California Res. Ctr /ID# 265549, Coronado
UC San Diego Health System /ID# 265565, La Jolla
uc davis medical center - patient support services building /ID# 265554, Sacramento

Се регрутираФаза 2

Возраст од 18 до 75 · Сите полови · Ажурирано 25.9.2026 · NCT06548542

A Study of Guselkumab in Pediatric Participants With Moderately to Severely Active Crohn's Disease

Cedars Sinai Medical Center, Los Angeles

Се регрутираФаза 3

Возраст од 2 до 17 · Сите полови · Ажурирано 25.9.2026 · NCT05923073

A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's Disease

United Medical Doctors, Murrieta
UCI Health, Orange

Се регрутираФаза 2

Возраст од 18 до 75 · Сите полови · Ажурирано 25.9.2026 · NCT06233461

A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease

Clinnova Research, Anaheim
Gastro Care Institute, Lancaster
United Gastroenterologists, Los Alamitos
и уште 3

Се регрутираФаза 3

Возраст 18 и постари · Сите полови · Ажурирано 25.9.2026 · NCT07499232

A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease

Clinnova Research, Anaheim
Southern California Research Center, Coronado
Om Research, LLC 1, Lancaster
и уште 6

Се регрутираФаза 2/3

Возраст 18 и постари · Сите полови · Ажурирано 25.9.2026 · NCT07196722

Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight

Smart Cures Clinical Research, Anaheim
Cedars-Sinai Medical Center, Beverly Hills
United Medical Doctors - Los Alamitos, Los Alamitos
и уште 1

Се регрутираФаза 3

Возраст од 18 до 70 · Сите полови · Ажурирано 24.9.2026 · NCT06937099

An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease

Alliance Research Institute-Site Number: 8400008, Canoga Park
Southern California GI & Liver Centers-Site Number: 8400062, Coronado
Gastroenterology and Liver Institute - Escondido-Site Number: 8400146, Escondido
и уште 14

Се регрутираФаза 3

Возраст од 16 до 80 · Сите полови · Ажурирано 23.9.2026 · NCT07184931

A Study to Assess Adverse Events, Change in Disease Activity, and How Intravenous and Subcutaneous Risankizumab Moves Through the Body of Pediatric Participants With Moderately to Severely Active Crohn's Disease

UCSF Benioff Children's Hospital - Oakland /ID# 258327, Oakland

Се регрутираФаза 3

Возраст од 2 до 17 · Сите полови · Ажурирано 23.9.2026 · NCT05995353

A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)

UCSF Medical Center at Mission Bay, San Francisco

Се регрутираФаза 3

Возраст од 2 до 19 · Сите полови · Ажурирано 22.9.2026 · NCT04844606

A Study of LY4395089 and Mirikizumab (LY3074828) Given Together and Mirikizumab (Alone) in Adults With Crohn's Disease

Biopharma Informatic, LLC, Los Angeles
Om Research LLC, Oxnard

Се регрутираФаза 2

Возраст од 18 до 80 · Сите полови · Ажурирано 22.9.2026 · NCT07483099

A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease

Gastro Care Institute, Lancaster
Infinity Clinical Research, San Diego

Се регрутираФаза 2

Возраст од 18 до 85 · Сите полови · Ажурирано 22.9.2026 · NCT06226883

A Master Protocol (IIBD): A Study of Multiple Drugs in Adults With Ulcerative Colitis or Crohn's Disease

Biopharma Informatic, LLC, Los Angeles
Om Research LLC, Oxnard

Се регрутираФаза 2

Возраст од 18 до 80 · Сите полови · Ажурирано 22.9.2026 · NCT07483073

A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's Disease

University of California San Diego Health (UCSD), La Jolla
Cedars-Sinai Medical Center, Los Angeles
Hoag Hospital Newport Beach, Newport Beach

Се регрутираФаза 4

Возраст од 18 до 70 · Сите полови · Ажурирано 9.9.2026 · NCT06045754

A Study of JNJ-78934804 in Participants With Moderately to Severely Active Crohn's Disease

Clinnova Research, Anaheim
Gastro SB Clinic, Chula Vista
United Medical Doctors, Los Alamitos
и уште 1

Се регрутираФаза 3

Возраст 18 и постари · Сите полови · Ажурирано 28.8.2026 · NCT07577843

A Study of Mirikizumab (LY3074828) in Pediatric Participants With Crohn's Disease

Cedars Sinai Medical Center, Los Angeles

Се регрутираФаза 3

Возраст од 2 до 17 · Сите полови · Ажурирано 24.8.2026 · NCT05509777

Treat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic Remission

Hoag Hospital, Irvine
UC San Diego Health, La Jolla
Cedars-Sinai, Los Angeles
и уште 1

Се регрутира

Возраст 18 и постари · Сите полови · Ажурирано 7.8.2026 · NCT05230173

A Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis or Crohn's Disease

Children's Hospital Of Orange County, Orange

Се регрутираФаза 3

Возраст од 2 до 17 · Сите полови · Ажурирано 3.8.2026 · NCT06100289

Crohn's Disease: Efficacy, Safety, and Pharmacokinetics of Upadacitinib in Pediatric Subjects With Moderately to Severely Active Crohn's Disease

UCSF Benioff Children's Hospital - Oakland /ID# 262217, Oakland
Lucile Packard Children's Hospital /ID# 262193, Palo Alto

Се регрутираФаза 3

Возраст од 2 до 17 · Сите полови · Ажурирано 24.6.2026 · NCT06332534

A Long-Term Extension Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis (UC) or Crohn's Disease (CD)

Loma Linda University, Loma Linda
Children's Hospital of Orange County, Orange
Stanford Children's Health, Palo Alto

Се регрутираФаза 3

Возраст од 2 до 17 · Сите полови · Ажурирано 22.6.2026 · NCT06405087

Moving Beyond Inflammation as a Therapeutic Target for Crohn's Disease

Cedars-Sinai Medical Center, Beverly Hills

Се регрутираФаза 2

Возраст од 18 до 80 · Сите полови · Ажурирано 5.6.2026 · NCT06976853

A Study of Vedolizumab With and Without Upadacitinib in Adults With Crohn's Disease

UCSD Medical Center, La Jolla
Keck Medicine Of USC - USC Healthcare Center 1, Los Angeles

Се регрутираФаза 3

Возраст од 18 до 65 · Сите полови · Ажурирано 27.5.2026 · NCT06227910

Clinical, Imaging, and Endoscopic Outcomes of Children Newly Diagnosed With Crohn's Disease

Cedars-Sinai, Los Angeles
UCSF Benioff Children's Hospitals, San Francisco

Се регрутираФаза 4

Возраст од 6 до 17 · Сите полови · Ажурирано 27.5.2026 · NCT05781152

A Study of Vedolizumab in Children With Ulcerative Colitis (UC) or Crohn's Disease (CD)

Rady Children's Hospital - San Diego - PIN, San Diego

Се регрутираФаза 3

Возраст 2 и постари · Сите полови · Ажурирано 7.5.2026 · NCT05442567

Precise Infliximab Exposure and Pharmacodynamic Control

Children's Hospital of Los Angeles, Los Angeles
Lucile Packard Children's Hospital Stanford, Palo Alto
Rady Children's Hospital San Diego, San Diego

Се регрутираФаза 2/3

Возраст од 6 до 22 · Сите полови · Ажурирано 5.5.2026 · NCT05660746

A Study of Vedolizumab in Children and Teenagers With Moderate to Severe Crohn's Disease (CD)

Rady Childrens Hospital San Diego - PIN, San Diego

Се регрутираФаза 3

Возраст од 2 до 17 · Сите полови · Ажурирано 5.5.2026 · NCT04779320

Efficacy and Safety of Obefazimod in Subjects With Moderately to Severely Active Crohn's Disease

Hoag Hospital, Irvine
United Medical Doctors, Murrieta

Се регрутираФаза 2

Возраст од 18 до 75 · Сите полови · Ажурирано 27.4.2026 · NCT06456593

A Study to Investigate Efficacy and Safety of SAR442970 in Patients With Crohn's Disease

Investigational Site Number: 8400005, Escondido
Investigational Site Number: 8400001, Lancaster

Се регрутираФаза 2

Возраст од 18 до 75 · Сите полови · Ажурирано 27.3.2026 · NCT06958536

Effect of Statins on Crohn's Disease

Stanford University, Stanford

Се регрутираРана фаза 1

Возраст од 18 до 80 · Сите полови · Ажурирано 27.2.2026 · NCT06538649

Impact of Prebiotics in Ulcerative Colitis

UCLA, Los Angeles

Се регрутира

Возраст од 18 до 85 · Сите полови · Ажурирано 27.2.2026 · NCT06495658

Stem Cell Transplantation in Crohn's Disease

Cedars-Sinai Medical Center, Los Angeles

Се регрутираФаза 1/2

Возраст од 13 до 28 · Сите полови · Ажурирано 20.2.2026 · NCT04224558

Treatment of Moderate to Severe Refractory Crohn's Disease

University of California, Davis, Sacramento
University of California, San Francisco, San Francisco

Се регрутираФаза 1/2

Возраст од 18 до 65 · Сите полови · Ажурирано 10.12.2025 · NCT06721962

Stelara and Tremfya Pregnancy Exposure Registry OTIS Autoimmune Diseases in Pregnancy Project

University of California, San Diego, La Jolla

Се регрутираНабљудувачка студија

Сите возрасти · Жени · Ажурирано 28.1.2025 · NCT02103361

Urine Metabolites in the Diagnosis of Disease

Unio Health Partners (Gastroenterology), Encinitas
Digestive Health Associates, Santa Monica
Westside Gastro Care, Santa Monica
и уште 1

Се регрутираНабљудувачка студијаДобредојдени се здрави волонтери

Возраст 18 и постари · Сите полови · Ажурирано 13.12.2024 · NCT06710067

Од ClinicalTrials.gov, податоци преземени 6.10.2026. Секоја студија ги поставува своите услови за вклучување; тимот на студијата одлучува кој може да учествува.